You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
以嶺藥業(002603.SZ):單硝酸異山梨酯片通過一致性評價
格隆匯 04-23 16:52

格隆匯4月23日丨以嶺藥業(002603.SZ)宣佈,近日,公司收到國家藥品監督管理局核准簽發的單硝酸異山梨酯片的《藥品補充申請批件》,該藥品通過仿製藥質量和療效一致性評價。單硝酸異山梨酯是一種硝酸酯類藥物,是臨牀常見的血管擴張藥物。

其臨牀適應症為:冠心病的長期治療;心絞痛的預防;心肌梗死後持續心絞痛的治療;與洋地黃和/或利尿劑聯合應用,治療慢性充血性心力衰竭。屬於國家醫保目錄甲類品種(2019年版)和國家基本藥物目錄品種(2018年版)。目前國內同品種只有2家通過了一致性評價。

公司表示,該品種通過一致性評價,有利於擴大產品的市場銷售,提高市場競爭力,對公司的經營業績產生積極影響,併為公司進行中的其他產品一致性評價工作積累寶貴的經驗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account